Omeros (OMER) Other Operating Expenses (2012 - 2026)
Omeros recorded quarterly Other Operating Expenses of $587000.0 in Q1 2026, down 97.8% quarter-over-quarter from $26.7 million in Q4 2020.
Omeros' Other Operating Expenses history runs 9 years deep, the most recent figure standing at $587000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $587000.0; the TTM figure through Mar 2026 stood at $587000.0 (changed N/A YoY), while the FY2025 annual figure was $237.6 million, changed N/A from the prior year.
- Other Operating Expenses came in at $587000.0 for Q1 2026 at Omeros, down from $26.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $587000.0 in Q1 2026 to a low of $587000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 587,000.00 |
| Dec 31, 2020 | 26.68 Mn |
| Sep 30, 2020 | 401,000.00 |
| Jun 30, 2020 | 147,000.00 |
| Mar 31, 2020 | 267,000.00 |
| Dec 31, 2019 | 28.68 Mn |
| Sep 30, 2019 | 278,000.00 |
| Jun 30, 2019 | 55,000.00 |
| Mar 31, 2019 | 131,000.00 |
| Dec 31, 2018 | 157,000.00 |
| Sep 30, 2018 | 36,000.00 |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 203,000.00 |
| Dec 31, 2017 | 466,000.00 |
| Sep 30, 2017 | 184,000.00 |
| Jun 30, 2017 | 157,000.00 |
| Mar 31, 2017 | 271,000.00 |
| Dec 31, 2016 | 380,000.00 |
| Sep 30, 2016 | 378,000.00 |
| Jun 30, 2016 | 327,000.00 |
| Mar 31, 2016 | 327,000.00 |
| Dec 31, 2015 | 417,000.00 |
| Sep 30, 2015 | 248,000.00 |
| Jun 30, 2015 | 365,000.00 |
| Mar 31, 2015 | 11,000.00 |
| Dec 31, 2013 | 12.50 Mn |
| Dec 31, 2012 | 3.95 Mn |
| Sep 30, 2012 | -3.95 Mn |
| Mar 31, 2012 | 7.20 Mn |